Products from BPS Bioscience
Sun, sea, and science: BPS Bioscience from San Diego, California promotes new scientific discoveries that lead to therapies by creating innovative solutions for research. BPS is an expert in recombinant proteins and enzymes, cell lines, virus-based tools, as well as biochemical and cellular assay systems. The high-quality products and services from BPS enable researchers worldwide to advance biological discoveries in a variety of disciplines, including epigenetics, cell signaling, SARS-CoV-2, immunotherapy, CRISPR, and adoptive cell therapies.
More information at: www.bpsbioscience.com
No results were found for the filter!
Firefly Luciferase A375 Cell line
Item number: BPS-82789
Firefly Luciferase A375 Cell Line is an A375 human melanoma cell line engineered to express Firefly luciferase driven by a CMV promoter. This cell line was generated by transduction with Firefly Luciferase Lentivirus (#79692-P).
| Keywords: | CDX Models, A375, |
| Application: | Internal co-culture killing assay control, in vitro/in vivo bioluminescence imaging |
1,781.00€
*
BAFF/APRIL Responsive TACI-NF-kappaB Luciferase Reporter...
Item number: BPS-82791
The BAFF/APRIL Responsive TACI-NF-kappaB Luciferase Reporter HEK293 Cell Line is a HEK293 cell line that expresses full-length human TACI (transmembrane activator and CAML interactor, also known as Tumor necrosis factor receptor superfamily member 13B or CD267) (NM_012452.3) under the control of a CMV promoter, for...
| Keywords: | TACI, TNFRSF13B, hCG_28297,, |
| Application: | TACI/NF-kappaB signaling pathway activity monitoring (cellular model), agent screening |
16,117.00€
*
MDM2-p53 Homogenous Assay Kit
Item number: BPS-82802
The MDM2-p53 Homogenous Assay Kit is designed to identify and assess the efficacy of inhibitors of MDM2 (mouse double minute 2 homolog) interaction with p53 by measuring their binding. The MDM2-p53 Homogeneous Assay Kit comes in a convenient 384-well AlphaLISA(R) format, with enough purified recombinant MDM2, p53,...
| Keywords: | E3 ubiquitin-protein ligase Mdm2, Double minute 2 protein (Hdm2), Oncoprotein Mdm2, RING-type E3 ubiquitin transferase... |
| Application: | Binding studies, screen small molecule inhibitor screening, drug discovery, HTS |
827.00€
*
CD200R1:CD200 [Biotinylated] Inhibitor Screening...
Item number: BPS-82806
The CD200R1:CD200 [Biotinylated] Inhibitor Screening Chemiluminescence Assay Kit is an ELISA designed to assess the efficacy of inhibitors of the binding between CD200R1 (CD200 receptor 1) and CD200 (cluster of differentiation 200) protein for screening and profiling applications. This kit comes with enough purified...
| Keywords: | CD200R1 ,CD200R, CRTR2, MOX2R, OX2R, Cell surface glycoprotein CD200 receptor 1, MOX1, MOX2, CD200, My033, OX-2 membrane... |
| Application: | Binding inhibitor screening/studies, drug discovery, HTS |
2,191.00€
*
CD20, VLP
Item number: BPS-102671-1
Human CD20 protein, full length encompassing amino acids 1-297(end). This construct is tag-free and was produced using VLP (virus-like particle) technology.
| Keywords: | Bp35, CD20, MS4A1, B-lymphocyte antigen CD20, B-lymphocyte surface antigen B1, Leukocyte surface antigen Leu-16,... |
| Application: | Animal immunization, ELISA, PK assay |
| Expressed in: | Human cells |
| Origin: | human |
| MW: | 34,3 kD |
From 582.00€
*
Mepolizumab
Item number: BPS-82842-1
Mepolizumab (SB 240563) is a humanized monoclonal antibody that binds to and neutralizes interleukin-5 (IL-5), the major cytokine involved in eosinophil proliferation, activation, and survival. Mepolizumab can be used for the research of eosinophilic granulomatosis with polyangiitis (EGPA) and severe eosinophilic...
| Keywords: | IL5, TRF, IL-5, Interleukin-5, T-cell replacing factor, B-cell differentiation factor I, Eosinophil differentiation factor, |
| Application: | FA (neutr.) |
| Species reactivity: | human |
From 603.00€
*
Benralizumab
Item number: BPS-82843-1
Benralizumab (MEDI-563) is an interleukin-5 receptor alpha (IL-5Ralpha)-directed cytolytic monoclonal antibody that induces direct, rapid and nearly complete depletion of eosinophils via enhanced antibody-dependent cell-mediated cytotoxicity. Benralizumab can be used for severe eosinophilic asthma.1
| Keywords: | IL5R, CD125, IL5RA, IL-5RA, CDw125, IL-5R-alpha, IL-5R subunit alpha, IL-5 receptor subunit alpha, Interleukin-5 receptor... |
| Application: | Eosinophil depletion |
| Species reactivity: | human |
From 2,079.00€
*
Bimagrumab
Item number: BPS-82876-1
Bimagrumab (Anti-ACVR2B Reference Antibody) is a human monoclonal antibody that blocks activin type II receptor (ActRII), with KDs of 1.7 pM and 434 pM for human ActRIIB and ActRIIA, respectively. Bimagrumab can be used for the research of pathological muscle loss and weakness.
| Keywords: | ACVR2B, ACTR-IIB, EC=2.7.11.30, Activin receptor type-2B, Activin receptor type IIB, |
| Application: | FC, ELISA, pathological muscle loss and weakness studies |
| Species reactivity: | human |
| MW: | 150 kD |
From 1,038.00€
*
